Glenview Trust’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,091
Closed -$229K 500
2025
Q2
$229K Sell
3,091
-203
-6% -$14.1K ﹤0.01% 469
2025
Q1
$266K Buy
3,294
+139
+4% +$11.9K 0.01% 425
2024
Q4
$247K Sell
3,155
-91
-3% -$7.74K ﹤0.01% 442
2024
Q3
$305K Buy
3,246
+243
+8% +$20.4K 0.01% 407
2024
Q2
$234K Buy
3,003
+50
+2% +$4.08K ﹤0.01% 431
2024
Q1
$268K Sell
2,953
-248
-8% -$20.6K 0.01% 416
2023
Q4
$248K Buy
3,201
+41
+1% +$2.87K 0.01% 430
2023
Q3
$215K Buy
3,160
+402
+15% +$29.2K 0.01% 428
2023
Q2
$224K Buy
2,758
+56
+2% +$4.47K 0.01% 433
2023
Q1
$222K Buy
+2,702
New +$193K 0.01% 420

Other funds holding GEHC

Glenview Trust's GEHC Position: Q3 2025 in Review

Glenview Trust sold out of GE HealthCare (GEHC) in Q3 2025, closing a stake of 3,091 shares — an estimated $229K sold.

Glenview Trust first reported a position in GEHC in Q1 2023 and held it in 10 quarters. The position peaked at $305K in Q3 2024. 1,279 funds tracked by Wall St. Rank hold GEHC as of Q3 2025.

  • Glenview Trust reported no remaining GE HealthCare position as of Q3 2025 after selling out during the quarter.
  • Glenview Trust sold 3,091 GE HealthCare shares in Q3 2025, an estimated $229K.
  • Glenview Trust first reported a position in GE HealthCare in Q1 2023 and held it in 10 quarters.
  • Glenview Trust's GE HealthCare position peaked at $305K in Q3 2024.
  • 1,279 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2025.

Based on Glenview Trust's 13F filing for Q3 2025, filed 7 Nov 2025.